BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Xeomin incobotulinumtoxinA regulatory update

Merz said CMS issued a temporary Q-code for Xeomin inco-botulinumtoxinA under Medicare Part B. The botulinum neurotoxin type A is...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >